Tandem Diabetes Care company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

tandemdiabetes.com

Founded Year

2006

Stage

IPO | IPO

Total Raised

$92.81M

Date of IPO

11/14/2013

Market Cap

4.60B

Stock Price

71.99

Revenue

$0000 

About Tandem Diabetes Care

Tandem Diabetes Care is dedicated to advancing the management of diabetes through new technologies, offering a user-centric and integrated approach to product design, development, and customer care.

Tandem Diabetes Care Headquarter Location

11075 Roselle St

San Diego, California, 92121,

United States

858-366-6900

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Tandem Diabetes Care

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Tandem Diabetes Care is included in 2 Expert Collections, including Diabetes.

D

Diabetes

1,750 items

M

Medical Devices

3,607 items

Companies that received FDA De Novo clearances since 2010. Companies tagged as #FDADeNovos

Tandem Diabetes Care Patents

Tandem Diabetes Care has filed 180 patents.

The 3 most popular patent topics include:

  • Insulin therapies
  • Diabetes
  • Implants (medicine)
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/4/2020

5/10/2022

Insulin therapies, Diabetes, Medical equipment, Implants (medicine), Dosage forms

Grant

Application Date

2/4/2020

Grant Date

5/10/2022

Title

Related Topics

Insulin therapies, Diabetes, Medical equipment, Implants (medicine), Dosage forms

Status

Grant

Latest Tandem Diabetes Care News

GlobalData Plc: Increasing Prevalence of Diabetes to Fuel the Demand for Insulin Pumps and Continuous Glucose Monitors

May 18, 2022

Middle East and Africa In North America, the US holds a dominating position in the insulin pumps and CGM market followed by Canada and Mexico. The market is majorly driven by the increasing prevalence rate of diabetes, increase in the prevalence of obesity, sedentary lifestyle, and increasing awareness among the consumers. Rapid innovation and advancements in technologies are also driving the market. Furthermore, reimbursement policies in the US provide great coverage of the device for the patients is one of the major factors that impact this market. For more regional insights on insulin pumps and continuous glucose monitors market, download a free report sample Key Insulin Pumps and Continuous Glucose Monitors Market Segments Insulin Pumps Leading Companies Medtronic plc, Abbott Laboratories, DexCom Inc, Insulet Corp, F. Hoffmann-La Roche Ltd, Ypsomed Holding AG, Tandem Diabetes Care Inc, and Zealand Pharma Insulin Pumps and Continuous Glucose Monitors Market Report Scope This market model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for – CMO executives who must have deep understanding of the insulin pumps and continuous glucose monitors marketplace to make strategic planning and investment decisions. Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management. Private equity investors that need a deeper understanding of the market to identify and value potential investment targets. Reasons to Buy Understand the impact of COVID-19 on insulin pumps and continuous glucose monitors market. Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline. Develop business strategies by understanding the trends shaping and driving insulin pumps and continuous glucose monitors market. Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the insulin pumps and continuous glucose monitors market in the future. Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders. Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage. Track device sales in the global and country-specific insulin pumps and continuous glucose monitors from 2015-2030. Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships. FAQs What was the insulin pumps and continuous glucose monitors market size in the year 2021? The insulin pumps and continuous glucose monitors market size was valued at $9.78 billion in 2021. Which are the key regions in the insulin pumps and continuous glucose monitors market? North America, South & Central America, Europe, Asia-Pacific, and Middle East & Africa are the key regions in the insulin pumps and continuous glucose monitors market. What are the key segments in the insulin pumps and continuous glucose monitors market? Insulin pumps and blood glucose meters are the key segments in the insulin pumps and continuous glucose monitors market. Which are the key companies in the insulin pumps and continuous glucose monitors market? Medtronic plc, Abbott Laboratories, DexCom Inc, Insulet Corp, F. Hoffmann-La Roche Ltd, Ypsomed Holding AG, Tandem Diabetes Care Inc, and Zealand Pharma are the key companies in the insulin pumps and continuous glucose monitors market. Related Reports Insulin Pens Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030 – Click h ere Blood Glucose Meters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 – Click h ere Continuous Glucose Monitors Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 – Click h ere Disposable Insulin Pumps Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 – Click h ere Artificial Pancreas Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 – Click h ere About us GlobalData is a leading provider of data, analytics, and insights on the world's largest industries. In an increasingly fast-moving, complex, and uncertain world, it has never been harder for organizations and decision makers to predict and navigate the future. This is why GlobalData's mission is to help our clients to decode the future and profit from faster, more informed decisions. As a leading information services company, thousands of clients rely on GlobalData for trusted, timely, and actionable intelligence. Our solutions are designed to provide a daily edge to professionals within corporations, financial institutions, professional services, and government agencies. Media Contacts

Tandem Diabetes Care Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Tandem Diabetes Care Rank

  • When was Tandem Diabetes Care founded?

    Tandem Diabetes Care was founded in 2006.

  • Where is Tandem Diabetes Care's headquarters?

    Tandem Diabetes Care's headquarters is located at 11075 Roselle St, San Diego.

  • What is Tandem Diabetes Care's latest funding round?

    Tandem Diabetes Care's latest funding round is IPO.

  • How much did Tandem Diabetes Care raise?

    Tandem Diabetes Care raised a total of $92.81M.

  • Who are Tandem Diabetes Care's competitors?

    Competitors of Tandem Diabetes Care include AlterG, Keystone Dental, CeQur, EOFlow, Acelity, Calibra Medical, Beta-O2 Technologies, Pharmacyclics, Spiracur, Small Bone Innovations and 20 more.

You May Also Like

A
Aksys

has developed an automated personal hemodialysis system for patient-performed hemodialysis in alternative care settings such as the patient's home.

Kinetic Muscles Logo
Kinetic Muscles

Kinetic Muscles Inc, KMI, engineers and manufactures products for stroke recovery. Used in physical therapy and occpational therapy clinics, KMI's products for stroke rehabilitation help improve the quality of life of stroke survivors.

M
Mercator MedSystems

Mercator MedSystems has developed a broad-based therapeutic platform that allows clinicians to accurately and efficiently deliver drugs and biologics such as stem cells to tissues deep in the body, treating the root cause of significant medical conditions. The company utilizes its family of Micro-Infusion Catheters for targeted treatments via the vascular system, including peripheral artery disease (PAD) and resistant hypertension (HTN); and via the bronchial tree, including malignant airway obstruction secondary to lung cancer. The company's 510(k)-cleared and CE-Marked Cricket and Bullfrog Micro-Infusion Catheters are vascular-access systems that are able to inject drugs, genes, and cells safely through vessel walls into deep tissues without major surgery.

Keystone Dental Logo
Keystone Dental

Keystone Dental is an oral healthcare company dedicated to the delivery of dental technology. The company's product portfolio includes Genesis, The Biomimetic Implant System, The Prima Implant System, DynaMatrix Extracellular Membrane, DynaBlast and DynaGraft bone graft substitutes, and Accell Connexus, a next-generation bioactive bone grafting product.

M
MetaCure

MetaCure is a clinical-stage device company focused on the treatment of adult type II diabetes via an implantable pulse generator delivering electrical stimulation via gastric contractility modulation.

D
Daverci Solutions

Daverci Solutions aims to make electronic medication management systems for long-term care facilities and the institutional pharmacies that supply them.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.